Patriarch Bartholomew: Interreligious dialogue is one of Phanar priorities
Pope Francis and Patriarch Bartholomew. Photo: vaticannews.va
On February 20, 2021, the head of Phanar, Patriarch Bartholomew, announced that one of the priorities of the Patriarchate of Constantinople is interreligious dialogue, reports Romfea publication.
Addressing Metropolitan Emmanuel (Adamakis) on the occasion of his appointment to the Chalcedonian See, Patriarch Bartholomew emphasized his "valuable contribution to the promotion of inter-Christian and inter-religious dialogues being one of the priorities of the Ecumenical Patriarchate."
The head of Phanar also stated that the "Orthodox testimony to European institutions in Brussels", carried out by Metropolitan Emmanuel on behalf of the Patriarchate of Constantinople, "was violated due to the incoherent creation of many branches representing various Orthodox Autocephalous Churches."
Earlier, the UOJ wrote that according to the head of Phanar, those calling ecumenism as heresy break the unity of the Church.
Read also
UOC Primate blesses special prayer rule for Great Lent
Metropolitan Onuphry blessed to pray for peace in Ukraine during Great Lent.
In Britain, Christians are no longer majority
According to a Pew Research Center study, the share of Christians in the United Kingdom has fallen below 50%.
His Beatitude Onuphry addresses flock before Great Lent
The Primate of the UOC blessed the faithful for the upcoming Great Lent.
Lavra Reserve complains to UNESCO about heating and power outage
International experts studied possible threats to the Kyiv-Pechersk Lavra – from missile strikes to power and heating outages.
Konotop Eparchy Administration is under repair after shelling
The replacement of the windows damaged as a result of the shelling in the Church of All Saints and the building of the Konotop Eparchy has become possible thanks to donations from believers.
Priests and laity of Rivne Eparchy donate blood for children with cancer
In Rivne, the UOC clergy and laity have donated blood for children undergoing treatment for cancer.